Results - Announcements
Acutaas Chemicals Ltd share price climbed 6.67% to Rs 3347.85 after the company's net profit jumped 64.21% to Rs 123.14 crore, while revenue from operations gained significantly 32.53% to Rs 436.92 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.54 lakh crore, easing 3.34%. It has marginally improved by 0.07% over last one week and softened by 3.01% in last one month while the market capitalization of Acutaas Chemicals Ltd has improved by 2.85% and 1.21% in the same period respectively.
Profit before tax (PBT) of Acutaas Chemicals Ltd stood at Rs 167.36 crore in Q3 FY26, expanding by 74.01% year-on-year, and surging by 61.06% quarter-on-quarter. EBITDA came in at Rs 171 crore, jumping 99.89% YoY and rallying 53.56% sequentially.
Total expenses witnessed a sharp rise of 20.85% to Rs 273.64 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 156.49 crore, slightly declining by 5.60% YoY, while employee benefits expense was at Rs 42.06 crore, ticking higher by 6.29% YoY.
For the TTM ended FY26, revenue from operations soared by 33.02% to Rs 1339.37 crore, while net profit surged by 122.15% to Rs 356.37 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 22351% to Rs 438.81 crore, and PBT witnessed a strong rise of 123.32% to Rs 482.73 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 292.17 crore in FY26, as against Rs 118.34 crore in FY25.
Acutaas Chemicals Ltd rallied 93.13% in last one year, significantly outperforming the benchmark BSE Sensex which has declined by 13.18% during the same period.